Entity Details

Primary name FCG3A_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP08637
EntryNameFCG3A_HUMAN
FullNameLow affinity immunoglobulin gamma Fc region receptor III-A
TaxID9606
Evidenceevidence at protein level
Length254
SequenceStatuscomplete
DateCreated1988-08-01
DateModified2021-06-02

Ontological Relatives

GenesFCGR3A

GO terms

Show/Hide Table
GOName
GO:0002862 negative regulation of inflammatory response to antigenic stimulus
GO:0004888 transmembrane signaling receptor activity
GO:0005886 plasma membrane
GO:0005887 integral component of plasma membrane
GO:0006955 immune response
GO:0007166 cell surface receptor signaling pathway
GO:0009897 external side of plasma membrane
GO:0018149 peptide cross-linking
GO:0019864 IgG binding
GO:0038096 Fc-gamma receptor signaling pathway involved in phagocytosis
GO:0050776 regulation of immune response
GO:0070062 extracellular exosome

Subcellular Location

Show/Hide Table
Subcellular Location
Cell membrane
Secreted

Domains

Show/Hide Table
DomainNameCategoryType
IPR003599 Immunoglobulin subtypeDomainDomain
IPR007110 Immunoglobulin-like domainDomainDomain
IPR013783 Immunoglobulin-like foldFamilyHomologous superfamily
IPR036179 Immunoglobulin-like domain superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
615707 OMIMImmunodeficiency 20 (IMD20)A rare autosomal recessive primary immunodeficiency characterized by functional deficiency of NK cells. Affected individuals typically present with severe herpes viral infections, particularly Epstein Barr virus (EBV), and human papillomavirus (HPV). The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00002 CetuximabDrugbankbiotech
DB00005 EtanerceptDrugbankbiotech
DB00028 Human immunoglobulin GDrugbankbiotech
DB00056 Gemtuzumab ozogamicinDrugbankbiotech
DB00087 AlemtuzumabDrugbankbiotech
DB00092 AlefaceptDrugbankbiotech
DB00110 PalivizumabDrugbankbiotech
DB00111 DaclizumabDrugbankbiotech
DB00112 BevacizumabDrugbankbiotech
DB06607 CatumaxomabDrugbankbiotech
DB11767 SarilumabDrugbankbiotech
DB12023 BenralizumabDrugbankbiotech